James R. Prudent

Eragen Biosciences, Inc.

$3,170,921

Attributed

$3,170,921

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $224.7K · FY2011–14

$250K$187.5K$125K$62.5K$0

'11

'12

'13

'14

Funding mix

By agency

NIH$3,170,921 · 9

By mechanism

R44$1,767,571 · 2

R43$1,053,102 · 6

R41$350,248 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Genetic Screening”

Richard A Gibbs · Baylor College Of Medicine$250,166,309
David R. Weir · University Of Michigan At Ann Arbor$227,469,694
Peter B. Gilbert · Fred Hutchinson Cancer Center$146,111,713
Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
William George Nelson · Johns Hopkins University$93,425,715
Stephen S. Rich · University Of Alabama At Birmingham$62,168,485

Research focus

Genetic ScreeningDiagnosis Design /EvaluationClinical ResearchPolymerase Chain ReactionTechnology /Technique DevelopmentHuman TissueGene MutationBiotechnologyGene ExpressionDiagnostic TestsCystic FibrosisCommunicable Disease DiagnosisMolecular Biology Information SystemGenotypeChloride ChannelsBacillus AnthracisFrancisella TularensisClostridium BotulinumAllelesMicroorganism GeneticsMonitoring DeviceBioterrorism /Chemical WarfareCrimean Congo Hemorrhagic Fever VirusNucleic Acid Sequence